KATY News Alert Katy Ind Inc (KATY) 1.7895 02/15/2015 00:44:

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Katy Ind Inc (KATY) 1.7895 $KATY

Katy Industries, Inc. Reports Net Income in 2014 Third Quarter Results
Marketwired - Mon Nov 10, 12:50PM CST
Katy Industries, Inc. (OTCBB: KATY) today reported net income in the third quarter of 2014 of $1.4 million, or $0.17 per basic ($0.05 per diluted) share versus net income of $0.2 million, or $0.02 per basic ($0.00 per diluted) share, in the third quarter of 2013. Income from continuing operations was $1.4 million in the third quarter of 2014 compared to income of $0.2 million in the third quarter of 2013. Operating income was $1.5 million, or 5.8% of net sales, in the third quarter of 2014, compared to income of $0.4 million, or 2.0% of net sales, for the same period in 2013.

Katy Industries posts lower net income of USD0.5m for Q2 2014
M2 - Tue Aug 12, 6:16AM CDT
Commercial cleaning company Katy Industries (OTC BB:KATY) disclosed on Monday its net income of USD0.5m (USD0.07 per basic, USD0.02 per diluted share) in the second quarter of 2014.

Katy Industries, Inc. Reports Net Income In 2014 Second Quarter Results
PR Newswire - Mon Aug 11, 3:21PM CDT
Katy Industries, Inc. (OTC BB: KATY) today reported net income in the second quarter of 2014 of $0.5 million, or $0.07 per basic ($0.02 per diluted) share versus net income of $0.1 million, or $0.02 per basic ($0.01 per diluted) share, in the second quarter of 2013. Income from continuing operations was $0.5 million in the second quarter of 2014 compared to income of $0.3 million in the second quarter of 2013. Operating income was $0.8 million, or 3.1% of net sales, in the second quarter of 2014, compared to income of $0.5 million, or 2.4% of net sales, for the same period in 2013.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Insights from the New First Presidency on Global Challenges

Updated Category News Views 218

A Historic Conversation with the First Presidency The recent interview featuring the new First Presidency of The Church of Jesus Christ of Latter-day Saints marks an exciting milestone. Conducted by the talented Jane Clayson Johnson, this unique dialogue sheds light on pressing issues within the Church and broader society. It was their first public discussion, making it a...

Continue Reading
Major Bets on Donald Trump's Election Surge Past $52 Million

Updated Category News Views 119

Significant Bets on Trump's Electoral Success A trader on Polymarket, operating under the alias Fredi9999, alongside four other accounts, has made headlines recently by placing enormous bets on Donald Trump’s electoral prospects. This activity has generated considerable chatter among traders in the market. Tracking Trump's Betting Activity Harry Crane, a statistics...

Continue Reading
FMC Corporation Faces Lawsuit Over Securities Violations

Updated Category News Views 190

FMC Corporation Faces Lawsuit Over Securities Violations Recently, the Gross Law Firm has alerted shareholders of FMC Corporation (NYSE: FMC) regarding significant legal developments. This lawsuit brings attention to serious allegations concerning the company's conduct during a specific class period. Shareholder Engagement and Participation Shareholders who purchased FMC...

Continue Reading
Insider Buying at Optima Health Signals Confidence in Future Growth

Updated Category News Views 132

Insightful Insider Share Purchase at Optima Health Optima Health plc (AIM: OPT), a leading provider of corporate health and wellbeing solutions in the UK, recently announced an important transaction involving one of its key insiders. Joanne Newey, who takes on the role of Group Business Development & Propositions Director and is also a Person Discharging Managerial...

Continue Reading
Outlook Therapeutics Prepares for Upcoming Investor Interaction

Updated Category News Views 78

Outlook Therapeutics Connects with Investors at Upcoming Virtual Event ISELIN, N.J. — Outlook Therapeutics, Inc. (Nasdaq: OTLK) has been making waves in the biopharmaceutical field with its groundbreaking ocular therapy. This marks an exciting era for the company following the recent approval of its eye treatment formulation of bevacizumab, which targets wet age-related...

Continue Reading